Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07203326 · ClinicalTrials.gov registry record · Phase 4
Microderm for Root Coverage Procedures
A Phase 4 study of Connective Tissue Graft and Gum Recession, sponsored by Ohio State University.
- Active
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07203326: Active Phase 4 study of Connective Tissue Graft and Gum Recession, sponsored by Ohio State University.
NCT07203326 is a Phase 4 study of Connective Tissue Graft and Gum Recession that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07203326, a Phase 4 study of Connective Tissue Graft and Gum Recession, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized pilot study will compare Acellular Dermal Matrix (ADM) and a microsurfaced Acellular Dermal Matrix (mADM) for wound healing, root coverage, gum tissue coverage of the surgical site, blood flow to the site, and patient comfort.
Primary Outcome
To compare the wound healing of root coverage procedures, and the gain of root coverage using either a new microsurfaced Acellular Dermal Matrix(mADM) or Acellular Dermal Matrix (ADM).
Conditions Studied
Interventions
- BIOLOGICAL Alloderm
- BIOLOGICAL MicroDerm
Study Locations (1)
Ohio
- The Ohio State University College of Dentistry - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-02-13 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
What the registry record for NCT07203326 still lists
NCT07203326 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Connective Tissue Graft appearing as the primary indexed condition, and to 2 interventions - of which Alloderm is the first listed.
NCT07203326 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07203326 about?
NCT07203326 is a clinical study titled "Microderm for Root Coverage Procedures". This randomized pilot study will compare Acellular Dermal Matrix (ADM) and a microsurfaced Acellular Dermal Matrix (mADM) for wound healing, root coverage, gum tissue coverage of the surgical site, blood flow to the site, and patient comfort.
What is the current status of trial NCT07203326?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2025-02-13. Estimated completion is 2026-12.
What conditions does trial NCT07203326 study?
This clinical trial studies the following conditions: Connective Tissue Graft, Gum Recession.
What interventions are being tested in trial NCT07203326?
The interventions under investigation include: Alloderm (BIOLOGICAL), MicroDerm (BIOLOGICAL).
Who is sponsoring clinical trial NCT07203326?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07203326 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07203326's enrollment target sits among peer trials
20 1753rd of 2000 higher than 168 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI